SAN FRANCISCO, Jan. 24, 2017 -- Hagens Berman Sobol Shapiro LLP alerts investors in Novo Nordisk A/S (NYSE:NVO) to the expanded class period and reminds them of the March 13, 2017 Lead Plaintiff deadline.
If you purchased or otherwise acquired NVO between February 5, 2015 and October 27, 2016 and suffered over $100,000 in losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/NVO
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
After repeatedly assuring investors of sales and profit growth, NVO announced its second consecutive quarter of disappointing earnings and slashed long-term profit-growth forecasts by 50% on October 28, 2016. In addition, NVO revealed it was being investigated by the U.S. Attorney’s Office for potentially improper arrangements with pharmacy benefits managers who purchase NVO’s insulin products. This news drove the price of the Company’s ADRs down approximately 13%.
“We’re focused on NVO’s insulin, and other, pricing-related matters and Defendants’ growth-related statements,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding NVO should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
First Western Ship Transits Strait of Hormuz Since Iran War Began
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Apple Turns 50: From Garage Startup to AI Crossroads
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 



